Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Activist Cannell Capital Loves Micro-Caps

Activist investor J. Carlo Cannell leads his fund Cannell Capital in a non-conventional way. Cannell established his fund in 1992 with just $600,000. Currently the firm has about $437 million worth of regulatory assets under management. Prior to establishing his own firm, Cannell worked at Dakin Securities, an investment bank in San Francisco. During the second quarter the market value of Cannell Capital’s public equity portfolio decreased from $319.86 million to $305.71 million. A hefty 32% of these holdings belonged to the technology sector. More interestingly, the top three equity positions of the fund as of June 30 all belonged to the micro-cap category, according to the fund’s recent 13F filing, a reflection of Cannell’s disregard towards the efficient market hypothesis, and his penchant for inefficient markets to seek large returns. We decided to take a closer look at the the firm’s top picks, which included GTT Communications Inc (NYSE:GTT), Intralinks Holdings Inc (NYSE:IL), and BioTelemetry, Inc. (NASDAQ:BEAT).

Carlo Cannell

We don’t just track the latest moves of hedge funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research which showed that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests, and easily beating the most popular large-cap picks of funds, which nonetheless get the majority of their collective capital. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic only the very best ideas of the best fund managers on your own? Since the beginning of forward testing in August 2012, the Insider Monkey small-cap strategy has outperformed the market every year, returning 118%, more than two times greater returns than the S&P 500 during the same period (see more details).

J. Carlo Cannell
J. Carlo Cannell
Cannell Capital

During the June quarter the fund reduced its holding in GTT Communications Inc (NYSE:GTT) by 14% to 1.75 million shares valued at $41.67 million. The firm’s top equity holding represents 13.63% of its portfolio and amasses 5.39% of the $859.84 million technology company’s outstanding shares. The reduction to its stake probably has more to do with profit taking rather than a glum outlook of the company, since GTT Communications Inc (NYSE:GTT)’s shares have accelerated by more than 86% year-to-date. In its financial results for the second quarter the provider of cloud networking services reported a net loss per share of $0.32, which came down to $0.07 after adjusting for severance costs and met Wall Street’s expectations. Julian Allen‘s Spitfire Capital is another large stockholder of GTT Communications Inc (NYSE:GTT) which also decreased its holding in the company during the second trimester, by 10% to 1.38 million shares valued at $32.98 million.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.